CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation
Jae Ha Lee, Jin Han Park, Ji Hoon Jang, Se Hun Kim, Sung Yong Hong, Woon Heo, Dong-Hwan Lee, Hye Sook Choi, Ki Hoon Kim, Hang-Jea Jang
Acute and Critical Care. 2022;37(2):177-184.   Published online 2022 April 20    DOI: https://doi.org/10.4266/acc.2021.01312

Excel Download

The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation
Acute and Critical Care. 2022;37(2):177-184   Crossref logo
Link1 Link2 Link3

Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation—A preliminary report
Journal of Pediatric Surgery. 1997;32(4):531-535   Crossref logo
Link1 Link2

Nafamostat Mesilate as a Regional Anticoagulant in Patients with Bleeding Complications during Extracorporeal Membrane Oxygenation
The International Journal of Artificial Organs. 2015;38(11):595-599   Crossref logo
Link1 Link2 Link3

Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
Journal of Korean Medical Science. 2011;26(7):945   Crossref logo
Link1 Link2 Link3

Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review
Artificial Organs. 2022;   Crossref logo
Link1 Link2 Link3

Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin
The Annals of Thoracic Surgery. 2016;102(2):534-539   Crossref logo
Link1 Link2

Extracorporeal membrane oxygenation with nafamostat mesilate as an anticoagulant for massive pulmonary hemorrhage after living-donor lobar lung transplantation
The Journal of Thoracic and Cardiovascular Surgery. 2002;124(3):626-627   Crossref logo
Link1 Link2

Experimental Results Using Nafamostat Mesilate as Anticoagulant During Extracorporeal Lung Assist for 24 Hours in Dogs
Artificial Organs. 2008;17(1):30-36   Crossref logo
Link1 Link2

Nafamostat Mesilate: A Regional Anticoagulant for Hemodialysis in Patients at High Risk for Bleeding
Nephron. 1993;64(3):376-381   Crossref logo
Link1 Link2

Sustained Deterioration of Hepatic Oxygenation After Nafamostat Mesilate-Induced Anaphylactic Shock During Hemodiafiltration
Artificial Organs. 2018;42(6):674-675   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Acute Crit Care has participated in CrossRef Text and Data Mining service since March 1, 2015.